Browse Category

Investment Insights News 25 December 2025 - 26 December 2025

London Stock Exchange Group (LSEG) Stock: Boxing Day Snapshot, Buyback Moves, AI Partnerships, and Analyst Forecasts (26 December 2025)

London Stock Exchange Group (LSEG) Stock: Boxing Day Snapshot, Buyback Moves, AI Partnerships, and Analyst Forecasts (26 December 2025)

London Stock Exchange Group plc (LON: LSEG) heads into the final stretch of 2025 with a weirdly quiet tape—because the tape is literally paused. The London Stock Exchange is closed on Friday, 26 December (Boxing Day), following the early close on 24 December and the Christmas Day shutdown. MoneyWeek With markets shut, investors are using the pause to do what they always do when they can’t trade: re-run the narrative. And LSEG’s narrative in late 2025 has three big chapters: Below is what’s current as of 26 December 2025, spanning the latest available pricing, recent company activity, and the most
Panacea Biotec Share Price Surges on UNICEF Vaccine Contract Upgrade: News, Forecasts and Stock Analysis for 26 December 2025

Panacea Biotec Share Price Surges on UNICEF Vaccine Contract Upgrade: News, Forecasts and Stock Analysis for 26 December 2025

Panacea Biotec Limited (NSE: PANACEABIO, BSE: 531349) became one of India’s standout movers on Friday, December 26, 2025, after the company disclosed a meaningful upgrade to its UNICEF vaccine supply award—an update that immediately lit up the stock tape even as the broader market drifted in thin year-end trade. Business Standard By midday, Panacea Biotec’s share price was sharply higher and trading at levels not seen in weeks, supported by heavy volumes and a surge in traded value. The catalyst wasn’t vague “sentiment” or rumor—it was a concrete, exchange-filed change in contracted order values for a WHO pre-qualified pentavalent vaccine
Yangzijiang Shipbuilding (SGX: BS6) Stock: What’s Driving the Share Price, Analyst Targets, and 2026 Outlook on Dec 26, 2025

Yangzijiang Shipbuilding (SGX: BS6) Stock: What’s Driving the Share Price, Analyst Targets, and 2026 Outlook on Dec 26, 2025

Yangzijiang Shipbuilding (Holdings) Ltd (SGX: BS6) is ending 2025 near the top of its recent trading range, with investors weighing two forces that rarely coexist so neatly: a still-massive multi‑year orderbook that supports earnings visibility, and a more complicated external backdrop shaped by geopolitics, ship-financing friction, and stop‑start policy signals around shipping trade measures. As of Dec 26, 2025, the stock was last indicated around S$3.45, down 0.86% on the day (in a S$3.45–S$3.48 range) on about 2.0 million shares traded—typical of thinner year‑end liquidity. SG Investors Yangzijiang Shipbuilding share price today: near highs, but not without nerves Multiple market
Seatrium Limited Stock (SGX:5E2) on 26 Dec 2025: Maersk Settlement, Offshore Wind Risk, Analyst Forecasts, and 2026 Catalysts

Seatrium Limited Stock (SGX:5E2) on 26 Dec 2025: Maersk Settlement, Offshore Wind Risk, Analyst Forecasts, and 2026 Catalysts

Seatrium Limited stock (SGX:5E2) is back on many investors’ radar on 26 December 2025, with the counter trading around S$2.14 (+0.47%) as of 13:59 Singapore time, according to market data compiled by SGinvestors. SG Investors The renewed attention isn’t happening in a vacuum. Over the past week, Seatrium has moved from a headline-grabbing legal dispute to a defined delivery-and-payment path on a major offshore wind vessel—just as the US offshore wind sector faces fresh political turbulence. Add to that a large multi-year order book spanning offshore wind, oil & gas floaters, and ship repair, and you have a stock with
Coeur Mining (CDE) Stock Before the Market Opens Dec. 26, 2025: New Gold Deal Updates, Latest Company News, Analyst Forecasts, and What to Watch

Coeur Mining (CDE) Stock Before the Market Opens Dec. 26, 2025: New Gold Deal Updates, Latest Company News, Analyst Forecasts, and What to Watch

U.S. markets reopen after the Dec. 25 holiday with investors turning back to one of 2025’s standout precious-metals names: Coeur Mining, Inc. (NYSE: CDE). Heading into the Friday, December 26, 2025 open, the story around CDE stock is less about a single headline and more about a fast-moving mix of M&A execution, cash-flow momentum, and gold/silver sentiment—all amplified by thin year-end liquidity. Below is what matters most right now, based on the latest filings, company updates, and current analyst and market coverage. Where Coeur Mining stock stands heading into the Dec. 26 open Coeur last traded at $18.72 (as of
Costco Stock (COST) Before Market Open Dec. 26, 2025: Earnings Takeaways, Tariff Headwinds, Analyst Targets, and the Next Catalysts

Costco Stock (COST) Before Market Open Dec. 26, 2025: Earnings Takeaways, Tariff Headwinds, Analyst Targets, and the Next Catalysts

U.S. markets reopen Friday, Dec. 26, 2025 for a full session, following an early close on Dec. 24 and the Christmas Day closure—even as federal offices were ordered shut for Dec. 24 and Dec. 26 (the exchanges are sticking to their normal schedule). Reuters For Costco Wholesale Corporation (NASDAQ: COST), the setup into the post-holiday session is defined by three big themes: (1) the company’s Q1 fiscal 2026 results and November sales trend, (2) tariff-related uncertainty and a closely watched legal fight to preserve potential duty refunds, and (3) a split Wall Street tape of upgrades/downgrades and price-target changes that
Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

Intuitive Surgical (ISRG) News, Analyst Forecasts and 2026 Outlook: FDA Expansion for da Vinci SP, Wall Street Targets, and What’s Next (Dec. 25, 2025)

December 25, 2025 — Intuitive Surgical, Inc. (NASDAQ: ISRG) is ending 2025 with two storylines that rarely move in sync: fresh regulatory momentum for its single-port robotic platform and a renewed valuation debate as analysts model what the next wave of procedure growth could look like in 2026. With U.S. markets closed for Christmas Day, ISRG was last quoted around the $578 level at the December 24 close, setting the stage for the next major catalyst: Intuitive’s Q4 2025 earnings expected in late January. MarketBeat Below is a comprehensive wrap of the latest news, forecasts, and analyst analysis available as
Philip Morris International (PM) in Focus on Dec. 25, 2025: Dividend Deadline, ZYN FDA Catalyst, and 2026 Stock Forecasts

Philip Morris International (PM) in Focus on Dec. 25, 2025: Dividend Deadline, ZYN FDA Catalyst, and 2026 Stock Forecasts

December 25, 2025 — With U.S. markets closed for the Christmas holiday, investor attention has shifted from intraday price moves to the next set of catalysts for Philip Morris International Inc. (NYSE: PM): a dividend deadline arriving tomorrow, an increasingly consequential FDA process around ZYN nicotine pouches, and a growing tug-of-war between “sin stock” discounts and a rapidly expanding smoke-free business. A cluster of fresh Christmas Day analyses frames the debate in unusually clear terms. One argues PM is still undervalued even after a strong year, another highlights the market’s persistent ethical discount for tobacco, while several forecast roundups show
Kenvue Stock (NYSE: KVUE) News Today: Kimberly-Clark Deal Update, Insider Buying, Analyst Forecasts — December 25, 2025

Kenvue Stock (NYSE: KVUE) News Today: Kimberly-Clark Deal Update, Insider Buying, Analyst Forecasts — December 25, 2025

U.S. markets are closed for Christmas Day (December 25, 2025), but investors aren’t exactly “off the clock” when it comes to Kenvue Inc. (NYSE: KVUE). The former Johnson & Johnson consumer-health spinout has become a live merger-arbitrage story after Kimberly-Clark agreed to buy it, and KVUE’s price action is now a referendum on deal timing, legal risk, and whether the takeover terms hold up through 2026. As of the most recent close (Wednesday, December 24), KVUE finished at $17.21, up 1.12%, with ~14.1 million shares traded—well below its recent average volume. MarketWatch Below is what’s on the tape for December
Tesla Stock After Hours on Christmas Day: TSLA Holds Near $485 — Key News, Analyst Forecasts, and What to Watch Before the Dec. 26 Open

Tesla Stock After Hours on Christmas Day: TSLA Holds Near $485 — Key News, Analyst Forecasts, and What to Watch Before the Dec. 26 Open

December 25, 2025 — Tesla, Inc. (NASDAQ: TSLA) stock is “after the bell” in a slightly unusual sense today: U.S. markets are closed for Christmas Day, so there is no fresh closing print on Dec. 25. The last bell rang on Christmas Eve (Wednesday, Dec. 24) during a holiday-shortened session, and Wall Street reopens for a full trading day on Friday, Dec. 26. Nasdaq With TSLA sitting near recent highs, investors are heading into Friday’s open focused on three overlapping storylines: (1) regulatory risk and safety scrutiny, (2) an intensifying “Q4 deliveries reality check,” and (3) Tesla’s robotaxi/autonomy narrative that
XRP Price Today at 10:20 (Dec 25, 2025): XRP Holds Near $1.87 as Spot ETF Assets Top $1.25B — Latest News, Forecasts, and Key Levels

XRP Price Today at 10:20 (Dec 25, 2025): XRP Holds Near $1.87 as Spot ETF Assets Top $1.25B — Latest News, Forecasts, and Key Levels

December 25, 2025 — XRP is trading in a tight, headline-driven range on Christmas Day, with investors weighing steady institutional accumulation through U.S. spot ETFs against muted spot-market momentum and year-end liquidity conditions. At 10:20 (timestamp shown on a real-time market feed), XRP traded at $1.8694, up about 0.36%, with the day’s range roughly $1.8537–$1.8805. Investing That “stuck-but-stable” tone is consistent with what multiple market watchers have emphasized in today’s coverage: ETF assets and inflows are rising, but price action remains compressed, suggesting the market is coiling for a larger move—up or down—once a catalyst breaks the stalemate. Mitrade XRP
UiPath Stock (PATH) Surges Ahead of S&P MidCap 400 Addition: Latest News, Forecasts, and What Comes Next

UiPath Stock (PATH) Surges Ahead of S&P MidCap 400 Addition: Latest News, Forecasts, and What Comes Next

December 25, 2025 — UiPath Inc. (NYSE: PATH) is closing out 2025 in the spotlight after a powerful, index-driven rally that pushed the automation software maker back onto investors’ year-end watchlists. With U.S. markets shut for Christmas Day, the conversation is now shifting from “why it moved” to “what the move changes”—for liquidity, ownership, and expectations heading into 2026. Reuters As of the most recent trade (the shortened Christmas Eve session), UiPath shares were around $17.16, after trading between roughly $16.70 and $17.36. What’s new on Dec. 25, 2025 isn’t a surprise product launch or an earnings shock. It’s a
1 19 20 21 22 23 67

Stock Market Today

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

7 February 2026
Ashtead shares closed Friday at 4,936p, up 1.09%, after the company bought 88,872 shares under its repurchase program. The group is set to shift its primary listing to New York on March 2, pending court approval, and will be removed from the FTSE UK index the same day. Ashtead paid a half-year dividend of 37.5 U.S. cents per share on Friday.
Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

7 February 2026
Beazley shares closed flat at 1,236 pence Friday as BlackRock disclosed a 6.55% stake and Vanguard reported 5.02%. Wellington Management cut its holding below 5%. The disclosures follow Zurich Insurance’s possible takeover offer of up to 1,335 pence per share, with a Feb. 16 deadline for a firm bid.
Go toTop